Filing Details

Accession Number:
0001209191-13-036534
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-12 18:57:35
Reporting Period:
2013-07-10
Filing Date:
2013-07-12
Accepted Time:
2013-07-12 18:57:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1356857 Trius Therapeutics Inc TSRX Pharmaceutical Preparations (2834) 201320630
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1479788 John Finn C/O Trius Therapeutics, Inc.
6310 Nancy Ridge Dr, # 105
San Diego CA 92121
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-07-10 1,000 $8.58 176,860 No 4 S Indirect By the John and Debbie Finn Trust
Common Stock Disposition 2013-07-11 500 $9.32 176,360 No 4 S Indirect By the John and Debbie Finn Trust
Common Stock Disposition 2013-07-12 5,000 $10.10 171,360 No 4 S Indirect By the John and Debbie Finn Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By the John and Debbie Finn Trust
No 4 S Indirect By the John and Debbie Finn Trust
No 4 S Indirect By the John and Debbie Finn Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,151 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012